Quantitative Prediction of Drug Interactions Caused by Cytochrome P450 2B6 Inhibition or Induction.
Veronica Di PaoloFrancesco Maria FerrariItalo PoggesiLuigi QuintieriPublished in: Clinical pharmacokinetics (2022)
This methodology can be used for proposing initial dose adaptations to be adopted, for example in clinical use or for designing DDI studies involving this enzyme.